Euro
USD
British Pound
NULL
Product Description
R-(+)-Etomoxir is a carnitine palmitoyltransferase I (CPT1) inhibitor which is required for the oxidation of long chain acyl CoA esters. It inhibits β-oxidation in mitochondria and shown to inhibit biosynthesis of cardiolipin from exogenous fatty acid in H9c2 cells. Potential antidiabetic drug.
R-(+)-Etomoxir is a carnitine palmitoyltransferase I (CPT1) inhibitor which is required for the oxidation of long chain acyl CoA esters. It inhibits β-oxidation in mitochondria and shown to inhibit biosynthesis of cardiolipin from exogenous fatty acid in H9c2 cells. Potential antidiabetic drug.
Biovision | B1104 | (R)-(+)-Etomoxir DataSheet
Alternate Name/Synonyms: (R)-2-[6-(4-Chlorophenoxy)hexyl]oxiranecarboxylic acid, ethyl ester
Appearance: Off-white Solid
Formulation: N/A
CAS Number: 124083-20-1
Structure Available?: Yes
Peptide sequence: N/A
Salt Form: Yes
Molecular Formula: C₁₇H₂₃ClO₄
Molecular Weight: 326.81
Cell-Permeable?: Yes
Purity: ≥98% by HPLC
Solubilities: DMSO (>8 mg/ml)
Handling: Protect from air and light
Country of Origin: USA
Tag Line: A carnitine palmitoyltransferase I (CPT1) inhibitor
MDL Number: MFCD11227266
PubChem CID: 60765
SMILES: CCOC(=O)C1(CO1)CCCCCCOC2=CC=C(C=C2)Cl
InChi: InChI=1S/C17H23ClO4/c1-2-20-16(19)17(13-22-17)11-5-3-4-6-12-21-15-9-7-14(18)8-10-15/h7-10H,2-6,11-13H2,1H3/t17-/m0/s1
InChi Key: DZLOHEOHWICNIL-KRWDZBQOSA-N
